Transfusion Medicine

Papers
(The TQCC of Transfusion Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Author Index17
Issue Information16
16
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda14
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage13
2021: That was the year that was12
Recruiting racialised youth to a stem cell registry in Canada11
Drivers of blood use in paediatric trauma: A retrospective cohort study10
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion10
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major10
Hemolysis during therapeutic plasma exchange: A rare phenomena9
Reflection from managing blood supply during social unrest9
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach9
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis9
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait8
SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: Laboratory information management systems: Are we ready for digital transformation?7
Plenary session III7
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding6
6
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia6
Placebo and nocebo effects in transfusion medicine6
Issue Information6
A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma6
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients6
Issue Information6
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene6
Issue Information5
Plenary II5
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia5
Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy5
Pitfalls of reasoning in hospital‐based transfusion medicine5
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population5
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient5
Lipidomic changes occurring in platelets during extended cold storage5
Author index5
D−− phenotype in a South Indian family: A multicentric approach to workup and management5
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors4
4
Poster Presentations4
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status4
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study4
4
Deviations in red cell blood component temperature during laboratory processing and at blood return monitored by a time–temperature indicator device4
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia4
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation4
Issue Information3
Lessons learned from the CONCOR‐1 trial3
An accurate genetic assay to identify human neutrophil antigen 2 deficiency3
The contribution and potential of older blood donors in Asia Pacific regions3
Chikungunya and Mayaro infective viruses in components of blood3
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic3
Primary or anamnestic antibody response to the D antigen (RhD)after bone grafting: Case report and implications3
Acute pancreatitis from a delayed haemolytic transfusion reaction3
Prevalence of anaemia among blood donors in eastern Morocco: The need for pre‐donation haemoglobin assessment3
A review of immunoglobulin use in a district general hospital setting3
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion3
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood3
It is not all anti‐policy attitudes: Viewing blood donation as a means to belong predicts blood donation among men who have sex with men3
3
Red blood cell transfusion in myelodysplastic syndromes: A systematic review3
Impact of elevated leukocyte levels on ABO blood group typing and cross‐matching3
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio3
Issue Information3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia3
3
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)2
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’2
Severe fetal anaemia due to red cell alloimmunisation in a Rhnull woman: A case report2
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation2
Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the United Kingdom2
Ferritin‐guided management of blood donors with a marginally low pre‐donation haemoglobin and its effect on the number of donations in the following 3 years2
Issue Information2
Plenary session III2
Issue Information2
Systematic literature review and meta‐analysis of concordance and accuracy of pretransfusion immunohematology routine tests2
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study2
Understanding hepcidin for iron management in pregnancy2
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐22
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England2
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease2
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour2
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures2
Plenary session I2
Review of transfusion practice for beta thalassaemia major patients in Scotland after removal of age criteria for red cell transfusion2
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada2
Fresh frozen plasma: Beyond coagulation factor content2
Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Knowledge and attitudes of apheresis donors regarding apheresis blood donation2
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important2
SARS‐CoV‐2 infection in the blood transfusion setting2
Universal new blood cell elution method with extensive phenotyping2
2
BGvar: A comprehensive resource for blood group immunogenetics2
2
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20152
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study1
Storage of thawed cryoprecipitate for 5 days at refrigerated temperatures: A systematic review and meta‐analysis1
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study1
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia1
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation1
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature1
Issue Information1
A case report of a rare p phenotype individual and a review of molecular biological analysis of p phenotype in the Chinese population1
Plenary III1
Wednesday 18 September 2024 Simultaneous sessions1
Extended red blood cell matching for all transfusion recipients is feasible1
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia1
Double or nothing: Costs of duplicate haematinic ordering in medical inpatients1
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities1
Issue Information1
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants1
Oral Abstracts1
Pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation treated with therapeutic plasma exchange: A case report1
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature1
Amber coloured plasma—Case for illustration1
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review1
Plasma exchange in acute hemolytic reaction due to ABO‐incompatible erythrocyte concentrate transfusions: Single center experience1
E‐learning/online education in transfusion medicine: A cross‐sectional international survey1
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors1
1
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation1
1
Validation of current commercially‐available devices to thaw pooled, solvent/detergent‐treated human plasma1
UK national survey of anticoagulation in extra‐corporeal photopheresis—Is it time for a UK consensus statement?1
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products1
Critical appraisal of knowledge, attitude and practice studies for blood donation in India1
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP1
Issue Information1
SARS‐CoV‐2‐associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues1
Poster session1
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso1
Guideline for the investigation and management of red cell antibodies in pregnancy: A British Society for Haematology guideline1
The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis1
Thursday 15th September 2022 Simultaneous sessions1
The importance of need‐altruism and kin‐altruism to blood donor behaviour for black and white people1
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype1
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study1
Two novel variant allele of the RHD gene detected in two Chinese blood donors with the RHD negative phenotype1
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo1
Recurrent pregnancy loss in a patient with anti‐Rh171
Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors1
Issue Information1
Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD1
1
Suggested blood donor deferral strategy regarding hepatitis B infections in China1
Cost analysis of care and blood transfusions in patients with Major Obstetric Haemorrhage in Ireland1
Plenary I1
Issue Information1
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) Stream of the BLOOD 2023 Meeting 5th – 8th November 2023, Melbourne, Australia1
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors1
Notes from the Basho of the blood service1
Does decreasing the incubation period used in the antibody screen affect its sensitivity?1
1
0.10484790802002